PMA

N18466: CMW BONE CEMENT

FDA PMA · BONE CEMENT · Depuy, Inc.

Key facts

PMA number N18466
Trade name CMW BONE CEMENT
Generic name BONE CEMENT
Applicant Depuy, Inc.
Owner/operator DePuy Synthes, Inc.
Product code LOD
Approval date Feb 22, 1984
Docket number 84M-0118
Notice date Apr 24, 1984
Establishment registration 8010379
FEI number 1000199976

At a glance

  • 10–99 Supplements
  • Oct 21, 1998 Latest supplement decision
  • No Withdrawn
  • No Summary of safety and effectiveness on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals